6-Methyl-2-(pyridin-4-yl)pyrimidin-4(3H)-one

Catalog No. :
ACANRG408
CAS No. :
59341-68-3
Molecular Formula :
C10H9N3O
Molecular Weight :
187.20

IUPAC Name:6-methyl-2-(pyridin-4-yl)pyrimidin-4(3H)-one

6-Methyl-2-(pyridin-4-yl)pyrimidin-4(3H)-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6-Methyl-2-(pyridin-4-yl)pyrimidin-4(3H)-one
IUPAC Name6-methyl-2-(pyridin-4-yl)pyrimidin-4(3H)-one
MDL No.MFCD11857960
Molecular FormulaC10H9N3O
Molecular Weight187.20
SMILESO=C1NC(C2=CC=NC=C2)=NC(C)=C1
InChI KeyUFMQZZRBKSOEKS-UHFFFAOYSA-N
Synonym2-(4-PYRIDYL)-4-HYDROXY-6-MENTHYL PYRIMIDINE;2-(4-Pyridyl)-4-hydroxy-6-methyl pyrimidine;6-methyl-2-pyridin-4-yl-pyrimidin-4-ol;6-methyl-2-pyridin-4-yl-1H-pyrimidin-4-one;6-Methyl-2-(pyridin-4-yl)pyriMidin-4(3H)-one;BUTTPARK 18\02-36;6-methyl-2-(pyridin-4-yl)-3,4-dihydropyrimidin-4-one;4-Hydroxy-6-methyl-2-(4-pyridyl)pyrimidine
CAS No.59341-68-3
PubChem CID135472977

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACANRG408 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACZSKX269 route compound structure diagram
    ACZSKX269623-58-5 In Stock
  2. Plus
  3. ACEXLC102 route compound structure diagram
    ACEXLC1026345-27-3 In Stock
  4. Then
  5. ACANRG408 route product structure diagram
    ACANRG40859341-68-3
Inquiry

2. ACANRG408 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCSRJ953 route compound structure diagram
    ACCSRJ9535977-14-0 In Stock
  2. Plus
  3. ACFQAT932 route compound structure diagram
    ACFQAT932100-48-1 In Stock
  4. Then
  5. ACANRG408 route product structure diagram
    ACANRG40859341-68-3
Inquiry

Comments (0)